Back to News
Market Impact: 0.2
One-Year Follow-up Study Confirms QuantalX’s Delphi-MD Measurements Predict Sustained Response to Ventriculoperitoneal Shunting in NPH
Source: Business Wire
Healthcare & BiotechTechnology & Innovation
QuantalX said a one-year follow-up study confirmed that its Delphi-MD measurements predict sustained response to ventriculoperitoneal shunting in patients with normal pressure hydrocephalus (NPH). The headline provides no study size, effect magnitude, or other numerical results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- Stocks slump, bonds leap as AI giants’ spending spooks investors
- PC chip plunge wipes out a quarter of Intel’s value
- Daiichi Sankyo’s first-half profit rises on cancer drug growth; shares up
- Intel plunges on a major guidance miss. What went wrong — and how to proceed
- Japan’s Nikkei slumps 3% as tech stocks tumble on AI worries
- Starbucks serves up a solid quarter and full-year outlook. Why we're staying invested